InvestorsHub Logo
Followers 8
Posts 547
Boards Moderated 0
Alias Born 12/28/2015

Re: Mariner93 post# 140412

Wednesday, 05/23/2018 9:15:28 AM

Wednesday, May 23, 2018 9:15:28 AM

Post# of 203913
I blame the bs on impatience. The recent Wall St. conference again has Hirsch state that short term is of no matter to the company, but long term expects to create "MASSIVE" value. I understand that statement loud and clear. What else do we need to know right now? We know the safety study will complete this quarter, sublingual tablet safety also wrapping up this quarter, MM study ramping up with Dr. Zeevi at the helm. We have a timeline of current trials and estimated completion times. I understand the safety is clearly late but has anyone but myself wondered if a botched safety trial was the reason Ziv and others were let go from the company and replaced with true professionals with solid track records. We may never know what the real reason for delay was but silence by the company may have been the best option considering investor sentiment at the time. Big thing coming my friend, Series A round complete 5 million in the bank and expect series b funding late this year as company truly starts ramping up.